Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
在Candel Therapeutics获得美国食品药品管理局用于治疗胰腺癌的 CAN-2409 孤儿药认定后,该公司股价走高
Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
在Candel Therapeutics获得美国食品药品管理局用于治疗胰腺癌的 CAN-2409 孤儿药认定后,该公司股价走高
使用浏览器的分享功能,分享给你的好友吧